Category Archives: Cell Therapy

Inclusive Body Myopathy Improvement After Stem Cell Therapy in Mumbai India
He is a case of Inclusive Body Myopathy, since last 16 years with the history of slowness in running speed and slipping of "chappals" while walking and following foot drop. Weakness is progressive in nature and now involved muscles of all 4 limbs and trunk. Since last 3 years he is bedridden. Muscle biopsy is showing Inclusive Body Myopathy and EMG-NCV reports are showing generalized primary muscle disease. His elder sister also suffering from the same problem. Neurologically, he is hypotonic and hyporeflexic. On examination: he has grade 1+ muscle power in all 4 limbs proximally and grade 0 foot muscles and grade 3 distal muscles of upper limbs. Proximal muscle weakness is more than distal. Functionally, he is dependent in all ADL and mobility. On FIM he scores 48. After Stem Cell Treatment 1. Stamina has increased. 2. He can do suspension exercises for more range of motion and with more repetition without fatigue. 3. Now he can initiate rolling. He takes less support for rolling and turning. Earlier he used to change his position 4-5 times because of discomfort, but now he needs to change his position only once at night. 4. He can initiate supine to sit. 5. He is able to perform side lying to sitting by himself upto 70%. 6. Attempted drinking water in modified manner with right hand, which he couldn #39;t do before. Stem Cell Therapy done at Dr Alok Shrama NeuroGen Brain and Spine Institute Surana Sethia Hospital Sion-Trombay Rd, Suman Ngr Opp Corporate Park, Chembur ...

By: neurogenbsi

Go here to see the original:
Inclusive Body Myopathy Improvement After Stem Cell Therapy in Mumbai India - Video

Spinal Cord Injury Improvement After Stem Cell Therapy in Mumbai India
She is a known case of Spinal Cord Injury since age of 1 year. After trauma she lost sensations of motor power below D6 level and on bowel bladder. MRI report showed 1) tiny focal traumatic contusion in cervical and upper dorsal spinal cord. 2) Grade 1 listhesis at C6-7 level. 3) Thin pre vertebral and anterior epidural hematoma. Initially she got good physiotherapy rehabilitation. She recovered in terms of bowel and bladder sensation, 50%. She has developed scoliosis (convexity towards right side) due to weakness of paravertebral muscles. Neurologically, she is hypertonic and hyperreflexic. She has ankle clonus. On examination: she has sensory loss below T6 level. She has grade 0 muscle power in bilateral lower extremities and near normal upper extremities strength. She is following time voiding for urination and she passes stool once in every 2-3 days. She has no pressure sores. On ASIA scale she scores "A". Functionally, she needs assistance in most ADL and wheelchair bound for mobility. On WeeFIM she scores 53. After Stem Cell Therapy 1. Exercises tolerance has increased. 2. Sitting posture is better. 3. She sits more erect now. Earlier, she used to stoop to one side. 4. Parents report that she responds to pain (being pinched on the side) now. Earlier would not be able to appreciate. Stem Cell Therapy done at Dr Alok Sharma NeuroGen Brain and Spine Institute Surana Sethia Hospital Sion-Trombay Rd, Suman Ngr Opp Corporate Park, Chembur, Mumbai -- 71. Tel : 022 ...

By: neurogenbsi

Follow this link:
Spinal Cord Injury Improvement After Stem Cell Therapy in Mumbai India - Video

Broadcast journalist says the results are dramatic By Cheche V. Moral Philippine Daily Inquirer

DAVILA and her firstborn David at age 10

You can point a mother to the ends of the earth and it wont weaken her resolve to find that cure for her ailing child.

Broadcast journalist Karen Davilas firstborn, David, was 3 years old when he was diagnosed with Pervasive Developmental Disorder, Not Otherwise Specified (PDD/NOS) in the Autism Spectrum, a severe form of autism. The development pediatrician said there was no cure for Davids condition.

David didnt have the classic signs of autism, but clearly he wasnt developing like other children his age, says Davila. At the age of 3, he wasnt speaking spontaneously, although he could read. He had tantrums, couldnt express his needs, whether he was hungry or sad, and didnt reach out to other children his age.

Like most kids in the autism spectrum, the boy had attention difficulties. He was spaced out most of the time, and was rigid. It was so heartbreaking to see my eldest this way, she adds.

Davila refused to accept that there was no answer to her sons condition. I researched endlessly and devoted myself to making sure my son got the best possible treatment, she says. She quickly put her son on a casein- and gluten-free diet and biomedical treatment, under the care of Defeat Autism Now (DAN)-licensed doctors.

Davila explains that kids like David lack an enzyme in the body to digest casein, a protein found in cows milk, and gluten, a protein found in wheat, oats, barley and rye. When they take [casein and gluten], it feels like opium in the body, so kids feel high, theyre so hyper, get wild and are spaced out.

David, now 11, has also undergone anti-fungal treatments, and has been taking supplements and B12 injections to help his attention issues. He has also benefited from the help of occupational and speech therapists. Now in Grade 5, David is in his grade level in Multiple Intelligence School, in a smaller class ratio, according to his mother.

Early last year, Davila was offered an opportunity to try the fresh cell therapy being offered by a clinic in Germany called Villa Medica. The stem cells are harvested from lamb fetus and injected into the patient. By then, the journalist-mom had read up on the supposed benefits of stem cell on children with special needs.

More here:
Karen Davila resorts to stem-cell therapy for son’s autism

Public release date: 11-Feb-2013 [ | E-mail | Share ]

Contact: Megan McCann memccann@nmh.org 312-926-5900 Northwestern Memorial Hospital

Each year, nearly 800,000 Americans suffer a stroke which can result in permanent brain damage, long term disability or death. As a leading cause of adult disability, stroke has an annual burden of more than $62 billion on the United States economy. With the exception of rehabilitation therapy, very few treatments are available to improve the chronic neurologic deficits caused by a stroke. In hopes of expanding therapeutic options, Northwestern Medicine researchers are investigating a novel stem cell therapy, known as SB623, that may hold the key to improving motor function following a disabling stroke.

Northwestern is currently one of only three sites in the nation enrolling participants in a landmark study to test the safety and efficacy of adult stem cell therapy for patients with stable ischemic stroke. Accounting for 87 percent of strokes, ischemic stroke occurs when a blocked artery interrupts the flow of oxygen and blood to the brain. This causes cell death and brain damage which can leave a person with impaired body functions, including paralysis, weakness on one side, difficulty with speech and language, vision issues, and cognitive challenges.

"Two million brain cells die each minute during a stroke making it critical to get treatment fast at the earliest sign of symptoms; once brain damage occurs, there's very little that can be done medically to reverse it," said principal investigator Joshua Rosenow, MD, director of Functional Neurosurgery at Northwestern Memorial Hospital and associate professor of neurosurgery, neurology, and physical medicine and rehabilitation at Northwestern University Feinberg School of Medicine. "While this study is only a preliminary step towards understanding the healing potential of these cells, we are excited about what a successful trial could do for a patient population that currently has very limited therapeutic options."

While the study's primary purpose is to examine the safety of SB623 stem cells, researchers will also seek to determine if the cells are effective in improving stroke symptoms. SB623 is derived from genetically engineered adult bone marrow cells from a healthy adult donor.

"Although not proven in humans, these stem cells have been shown to promote healing and improve function when administered in animal models of stable stroke," said co-investigator Richard Bernstein, MD, director of Northwestern Memorial's Stroke Center and associate professor of neurology at the Feinberg School. "The cells did not replace the neurons destroyed by stroke, but instead they appeared to encourage the brain to heal itself and promote the body's natural regenerative process. Eventually, the implanted stem cells disappeared."

"In this study, the cells are transplanted into the brain using brain mapping technology and scans, allowing us to precisely deposit the cells in the brain adjacent to the area damaged by stroke," explained Rosenow.

Early participants have received 2.5 million cells, but as the study progresses the dose will escalate to 5 million and eventually 10 million cells. Since SB623 cells are allogeneic, a single donor's cells can be used to treat many other individuals. Participants in the study will be followed for up to two years with periodic evaluations for safety and effectiveness in the improvement in motor function.

"Stroke can be a very disabling and life changing event," said Bernstein. "Even just a slight improvement in function could make a huge difference for a person impacted by stroke. To potentially give our patients the opportunity to permanently regain movement or speech is a very exciting prospect. In the animal models, the improvements appeared to remain even after the implanted stem cells disappeared."

Here is the original post:
Northwestern Medicine researchers investigate stem cell therapy for stroke

A growing number of wealthy Filipinos have availed themselves of the four-day, three-night treatment in Germany. Last year alone, the clinic attended to 350 Filipinos

DR.GEOFFREY Huertgen, Villa Medicas chief medical director. ALANAH TORRALBA

Jumpstarting the regeneration process to achieve longevity, glowing skin and youthful energy are just three of the claimed benefits derived by patients at Villa Medica.

The Germany-based holistic clinic specializes in fresh-cell therapy, a form of stem-cell treatment sourced from organs and tissues of unborn lamb.

Such claims may sound too good to be true, until you see the likes of former President Joseph Estrada, former first lady Imelda Marcos and Senate President Juan Ponce Enrile strutting about and plotting their next political moves like theyre in their prime.

Except for Enrile, Marcos and Estrada have nearly endorsed the clinic in Edenkoben, an hours drive south of Frankfurt, by agreeing to have their pictures and brief testimonials used in a Villa Medica brochure.

Marcos reportedly started having fresh-cell therapy injections in 1969, less than a decade after Villa Medica opened its doors for business in 1961. But the acknowledged father of fresh-cell therapy, Dr. Paul Niehans, broke ground and started his research in 1931.

Dr. Geoffrey Huertgen, Villa Medicas chief medical director, visited Manila two weeks ago to see former and potential patients. What the clinic promises, he said, is overall good health by enhancing the regeneration process. Youthful attributes such as beautiful skin and increased energy are just byproducts of the clinics holistic philosophy.

Active partner

Although fresh-cell therapy claims to help improve the condition of diabetics and kids afflicted with autism and Downs syndrome, to name a few, it doesnt promise a miracle cure for life-threatening diseases such as cancer. And since the clinics approach is organ-specific, it doesnt offer patients a one-size-fits-all therapy.

Continue reading here:
Estrada, Enrile, Imelda Marcos–how they’re defying age and time with stem-cell therapy